Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 329 of 329 entries
Sorted by: Best Match Show Resources per page
Patient posture correction and alignment using mixed reality visualization and the HoloLens 2.

Medical physics

Johnson PB, Jackson A, Saki M, Feldman E, Bradley J.
PMID: 34780068
Med Phys. 2022 Jan;49(1):15-22. doi: 10.1002/mp.15349. Epub 2021 Nov 22.

PURPOSE: The purpose of this study was to develop and preliminarily test a radiotherapy system for patient posture correction and alignment using mixed reality (MixR) visualization. The write-up of this work also provides an opportunity to introduce the concepts...

Cite
Johnson PB, Jackson A, Saki M, et al. Patient posture correction and alignment using mixed reality visualization and the HoloLens 2. Med Phys. 2021;49(1):15-22doi: 10.1002/mp.15349.
Johnson, P. B., Jackson, A., Saki, M., Feldman, E., & Bradley, J. (2022). Patient posture correction and alignment using mixed reality visualization and the HoloLens 2. Medical physics, 49(1), 15-22. https://doi.org/10.1002/mp.15349
Johnson, Perry B, et al. "Patient posture correction and alignment using mixed reality visualization and the HoloLens 2." Medical physics vol. 49,1 (2022): 15-22. doi: https://doi.org/10.1002/mp.15349
Johnson PB, Jackson A, Saki M, Feldman E, Bradley J. Patient posture correction and alignment using mixed reality visualization and the HoloLens 2. Med Phys. 2022 Jan;49(1):15-22. doi: 10.1002/mp.15349. Epub 2021 Nov 22. PMID: 34780068.
Copy Download .nbib Format: NLM
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.

Blood cancer journal

Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, Galkin I, Svelolkin V, Postovalova E, Bagaev A, Ovcharov P, Varlamova A, Huet S, Tesson B, McGrath KR, Slager S, Link BK, Syrbu S, Novak AJ, Habermann TM, Witzig TE, Nowakowski GS, Salles G, Cerhan JR, Ansell SM.
PMID: 34267181
Blood Cancer J. 2021 Jul 15;11(7):130. doi: 10.1038/s41408-021-00521-4.

Despite a characteristic indolent course, a substantial subset of follicular lymphoma (FL) patients has an early relapse with a poor outcome. Cells in the microenvironment may be a key contributor to treatment failure. We used a discovery and validation...

Cite
Mondello P, Fama A, Larson MC, et al. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood Cancer J. 2021;11(7):130doi: 10.1038/s41408-021-00521-4.
Mondello, P., Fama, A., Larson, M. C., Feldman, A. L., Villasboas, J. C., Yang, Z. Z., Galkin, I., Svelolkin, V., Postovalova, E., Bagaev, A., Ovcharov, P., Varlamova, A., Huet, S., Tesson, B., McGrath, K. R., Slager, S., Link, B. K., Syrbu, S., Novak, A. J., Habermann, T. M., Witzig, T. E., Nowakowski, G. S., Salles, G., Cerhan, J. R., & Ansell, S. M. (2021). Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood cancer journal, 11(7), 130. https://doi.org/10.1038/s41408-021-00521-4
Mondello, Patrizia, et al. "Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma." Blood cancer journal vol. 11,7 (2021): 130. doi: https://doi.org/10.1038/s41408-021-00521-4
Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, Galkin I, Svelolkin V, Postovalova E, Bagaev A, Ovcharov P, Varlamova A, Huet S, Tesson B, McGrath KR, Slager S, Link BK, Syrbu S, Novak AJ, Habermann TM, Witzig TE, Nowakowski GS, Salles G, Cerhan JR, Ansell SM. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood Cancer J. 2021 Jul 15;11(7):130. doi: 10.1038/s41408-021-00521-4. PMID: 34267181; PMCID: PMC8282842.
Copy Download .nbib Format: NLM
A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review.

Cureus

Hanna R, Feldman AM, Keller CE, Siddiqui MS.
PMID: 33329973
Cureus. 2020 Nov 13;12(11):e11477. doi: 10.7759/cureus.11477.

World Health Organization (WHO) grade I meningiomas are slow-growing and typically benign brain tumors that can often be easily removed by surgery and rarely become malignant. We report the case of a WHO grade I meningioma in a 67-year-old...

Cite
Hanna R, Feldman AM, Keller CE, et al. A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review. Cureus. 2020;12(11):e11477doi: 10.7759/cureus.11477.
Hanna, R., Feldman, A. M., Keller, C. E., & Siddiqui, M. S. (2020). A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review. Cureus, 12(11), e11477. https://doi.org/10.7759/cureus.11477
Hanna, Renee, et al. "A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review." Cureus vol. 12,11 (2020): e11477. doi: https://doi.org/10.7759/cureus.11477
Hanna R, Feldman AM, Keller CE, Siddiqui MS. A Grade I Intracranial Meningioma with Metastasis to Multiple Vertebral Bodies: A Case Report and Literature Review. Cureus. 2020 Nov 13;12(11):e11477. doi: 10.7759/cureus.11477. PMID: 33329973; PMCID: PMC7734695.
Copy Download .nbib Format: NLM
Development and Regulatory Challenges for Peptide Therapeutics.

International journal of toxicology

Zane D, Feldman PL, Sawyer T, Sobol Z, Hawes J.
PMID: 33327828
Int J Toxicol. 2021 Mar-Apr;40(2):108-124. doi: 10.1177/1091581820977846. Epub 2020 Dec 17.

There has been an increased interest in and activity for the use of peptide therapeutics to treat a variety of human diseases. The number of peptide drugs entering clinical development and the market has increased significantly over the past...

Cite
Zane D, Feldman PL, Sawyer T, et al. Development and Regulatory Challenges for Peptide Therapeutics. Int J Toxicol. 2020;40(2):108-124doi: 10.1177/1091581820977846.
Zane, D., Feldman, P. L., Sawyer, T., Sobol, Z., & Hawes, J. (2021). Development and Regulatory Challenges for Peptide Therapeutics. International journal of toxicology, 40(2), 108-124. https://doi.org/10.1177/1091581820977846
Zane, Doris, et al. "Development and Regulatory Challenges for Peptide Therapeutics." International journal of toxicology vol. 40,2 (2021): 108-124. doi: https://doi.org/10.1177/1091581820977846
Zane D, Feldman PL, Sawyer T, Sobol Z, Hawes J. Development and Regulatory Challenges for Peptide Therapeutics. Int J Toxicol. 2021 Mar-Apr;40(2):108-124. doi: 10.1177/1091581820977846. Epub 2020 Dec 17. PMID: 33327828.
Copy Download .nbib Format: NLM
Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death".

Roberts SF, Fischhoff MA, Sakowski SA, Feldman EL.
UIID-AD: 2862
2012;87:266-70. doi: 10.1097/ACM.0b013e3182446fa3.

Significant increases in National Institutes of Health (NIH) spending on medical research have not produced corresponding increases in new treatments and cures. Instead, laboratory discoveries remain in what has been termed the "valley of death," the gap between bench...

Cite
Roberts SF, Fischhoff MA, Sakowski SA, et al. Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". 2012;87:266-70doi: 10.1097/ACM.0b013e3182446fa3.
Roberts, S. F., Fischhoff, M. A., Sakowski, S. A., & Feldman, E. L. (2012). Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". 87266-70. https://doi.org/10.1097/ACM.0b013e3182446fa3
Roberts, S F, et al. "Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death"." vol. 87 (2012): 266-70. doi: https://doi.org/10.1097/ACM.0b013e3182446fa3
Roberts SF, Fischhoff MA, Sakowski SA, Feldman EL. Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". 2012;87:266-70. doi: 10.1097/ACM.0b013e3182446fa3. UIID-AD: 2862.
Copy Download .nbib Format: NLM
Showing 325 to 329 of 329 entries